Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Shimadzu Developing Next-generation DNA Sequencers
April 22, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 22, 2002
- MEDICAL DEVICE NEWS IN BRIEF
April 22, 2002
- Paxil's Sales Top \12 Bil. in 2001
April 22, 2002
- Meiji Seika to Promote Depromel to Non-specialists
April 22, 2002
- Hitachi Medical: Digital Ultrasound Diagnostic System
April 22, 2002
- Fujisawa Launches Protopic in Germany
April 22, 2002
- Olympus: VISERA Video System for Endoscopy
April 22, 2002
- AnGes MG Newly Agrees Agreement with Daiichi on HGF Gene Therapy
April 22, 2002
- Genzyme Promotes 4-Marker Maternal Serum Screening Test
April 22, 2002
- Nippon Roche, Chugai to Copromote Kytril
April 22, 2002
- Takeda: HICEE WHITE 2
April 22, 2002
- BUSINESS NEWS IN BRIEF
April 22, 2002
- Kyowa Hakko's Dacarbazine Approved for Hodgkin's Disease
April 15, 2002
- Ain Pharmaciez, Imagawa Yakuhin to Merge This November
April 15, 2002
- Asahi Kasei's Toledomin Shows Steady Growth in Sales
April 15, 2002
- Sugi Pharmacy: Sales Exceed \50 Bil.
April 15, 2002
- BUSINESS NEWS IN BRIEF
April 15, 2002
- OCT NEWS IN BREIF
April 15, 2002
- WEBSITE NEWS
April 15, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…